MONTA WRIGHT: Open Payments
NPI 1790186328 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$504 in 27 payments from 13 companies in 2025. Trend: 2023 $227 · 2024 $735 · 2025 $504
Food & beverage: $504
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $79 |
| AstraZeneca Pharmaceuticals LP | 4 | $66 |
| ABBVIE INC. | 3 | $62 |
| Novo Nordisk Inc | 2 | $50 |
| Gilead Sciences, Inc. | 2 | $38 |
| PFIZER INC. | 2 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $30 |
| Abbott Laboratories | 2 | $29 |
| Boston Scientific Corporation | 1 | $29 |
| Grifols USA, LLC | 1 | $26 |
Products named: MOUNJARO, Ozempic, VRAYLAR, AIRSUPRA, Kerendia, FREESTYLE LIBRE 3, WaveWriter Alpha Prime 16, Prolastin-C Liquid.
Industry payments across NC — which companies pay providers there.
